Gastrointestinal Stromal Tumor (GIST) Global Clinical Trials Review, H1, 2014

Date: March 12, 2014
Pages: 163
Price:
US$ 2,500.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: GE05C504601EN
Leaflet:

Download PDF Leaflet

Gastrointestinal Stromal Tumor (GIST) Global Clinical Trials Review, H1, 2014
Gastrointestinal Stromal Tumor (GIST) Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Gastrointestinal Stromal Tumor (GIST) Global Clinical Trials Review, H1, 2014' provides data on the Gastrointestinal Stromal Tumor (GIST) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Gastrointestinal Stromal Tumor (GIST). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Gastrointestinal Stromal Tumor (GIST). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Introduction
Gastrointestinal Stromal Tumor (GIST)
Report Guidance
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Gastrointestinal Stromal Tumor (GIST) to Oncology Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Gastrointestinal Stromal Tumor (GIST) to Oncology Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Unaccomplished Trials of Gastrointestinal Stromal Tumor (GIST)
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Gastrointestinal Stromal Tumor (GIST)
Jun 11, 2013: Ariad Pharma Initiates Phase II Trial Of Ponatinib In Patients With Gastrointestinal Stromal Tumors
Nov 21, 2012: Regorafenib Overcomes Resistance In Patients With Gastrointestinal Stromal Tumor After Failure Of Standard Targeted Therapies, Researchers Report
Oct 24, 2012: EirGen Pharma’s Cancer Product Eir-108 Passes Clinical Trial In Japan
Jun 01, 2012: Clinical Trial Design Supports Original Accelerated Approval Of Sunitinib For GIST, Study Reports
Apr 03, 2012: Bayer Announces Positive Results From Phase III Trial Evaluating Regorafenib In Patients With Metastatic Gastrointestinal Stromal Tumors
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Novartis AG
Clinical Trial Overview of Novartis AG
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Bayer AG
Clinical Trial Overview of Bayer AG
AB Science
Clinical Trial Overview of AB Science
GlaxoSmithKline plc
Clinical Trial Overview of GlaxoSmithKline plc
Sarcoma Alliance for Research through Collaboration
Clinical Trial Overview of Sarcoma Alliance for Research through Collaboration
Amgen Inc.
Clinical Trial Overview of Amgen Inc.
Infinity Pharmaceuticals, Inc.
Clinical Trial Overview of Infinity Pharmaceuticals, Inc.
AstraZeneca PLC
Clinical Trial Overview of AstraZeneca PLC
AEterna Zentaris Inc.
Clinical Trial Overview of AEterna Zentaris Inc.
Clinical Trial Overview of Top Institutes / Government
National Cancer Institute
Clinical Trial Overview of National Cancer Institute
European Organization for Research and Treatment of Cancer
Clinical Trial Overview of European Organization for Research and Treatment of Cancer
The University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
Stanford University
Clinical Trial Overview of Stanford University
Asan Medical Center
Clinical Trial Overview of Asan Medical Center
Radboud University
Clinical Trial Overview of Radboud University
Memorial Sloan Kettering Cancer Center
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
National University Hospital
Clinical Trial Overview of National University Hospital
Fox Chase Cancer Center
Clinical Trial Overview of Fox Chase Cancer Center
Technische Universitat Munchen
Clinical Trial Overview of Technische Universitat Munchen
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

LIST OF TABLES

Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Clinical Trials by Region, 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Europe, Top Five Countries, 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, North America, Top Countries, 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014
Proportion of Gastrointestinal Stromal Tumor (GIST) to Oncology Clinical Trials, G7 Countries (%), 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014
Proportion of Gastrointestinal Stromal Tumor (GIST) to Oncology Clinical Trials, E7 Countries (%), 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Clinical Trials by Phase, 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Clinical Trials In Progress by Phase 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Clinical Trials by Trial Status, 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Global, by End Point Status, 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Suspended Clinical Trials, 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Withdrawn Clinical Trials, 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Terminated Clinical Trials, 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
Gastrointestinal Stromal Tumor (GIST) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Global, Key Sponsors, 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials Market, Global, Clinical Trials by AB Science, 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarcoma Alliance for Research through Collaboration, 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials Market, Global, Clinical Trials by Infinity Pharmaceuticals, Inc., 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials Market, Global, Clinical Trials by AEterna Zentaris Inc., 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials Market, Global, Clinical Trials by National University Hospital, 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials Market, Global, Clinical Trials by Fox Chase Cancer Center, 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials Market, Global, Clinical Trials by Technische Universitat Munchen, 2014

LIST OF FIGURES

Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Clinical Trials by Region (%), 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, North America, Top Countries (%), 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014
Proportion of Gastrointestinal Stromal Tumor (GIST) to Oncology Clinical Trials, G7 Countries (%), 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014
Proportion of Gastrointestinal Stromal Tumor (GIST) to Oncology Clinical Trials, E7 Countries (%), 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Clinical Trials by Phase (%), 2014
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Clinical Trials by Trial Status, 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Global, by End Point Status, 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
Gastrointestinal Stromal Tumor (GIST) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Global, Key Sponsors, 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014
GlobalData Methodology

Ask Your Question

Gastrointestinal Stromal Tumor (GIST) Global Clinical Trials Review, H1, 2014
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: